These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27626149)

  • 1. Short-term effects of intravitreal dexamethasone implant (OZURDEX®) on choroidal thickness in patients with naive branch retinal vein occlusion.
    Arifoglu HB; Duru N; Altunel O; Baskan B; Alabay B; Atas M
    Arq Bras Oftalmol; 2016; 79(4):243-6. PubMed ID: 27626149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in choroidal thickness after intravitreal dexamethasone implant injection in retinal vein occlusion.
    Lee EK; Han JM; Hyon JY; Yu HG
    Br J Ophthalmol; 2015 Nov; 99(11):1543-9. PubMed ID: 25883084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHOROIDAL THICKNESS CHANGES AFTER INTRAVITREAL DEXAMETHASONE IMPLANT INJECTION FOR THE TREATMENT OF MACULAR EDEMA DUE TO RETINAL VEIN OCCLUSION.
    Esen E; Sizmaz S; Demircan N
    Retina; 2016 Dec; 36(12):2297-2303. PubMed ID: 27870799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
    Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
    Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Age on Dexamethasone Intravitreal Implant (Ozurdex®) Response in Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Altunel O; Göktaş A; Duru N; Özköse A; Arifoğlu HB; Ataş M
    Semin Ophthalmol; 2018; 33(2):179-184. PubMed ID: 27599562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of morphological and functional changes after repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion.
    Bandello F; Parravano M; Cavallero E; Cascavilla ML; Triolo G; Querques L; Borrelli E; Giorno P; Varano M; Lattanzio R; Querques G
    Ophthalmic Res; 2015; 53(4):207-16. PubMed ID: 25896233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
    Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
    Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Lee KH; Kang EC; Koh HJ
    Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-Term Assessment of Intravitreal Dexamethasone Implant Using Enhanced-Depth Image Optical Coherence Tomography and Optical Coherence Tomography Angiography in Patients with Retinal Vascular Diseases.
    Minnella AM; Federici M; Pagliei V; Lanza A; Gambini G; Caputo CG; Falsini B; Caporossi A
    Adv Ther; 2019 Feb; 36(2):416-425. PubMed ID: 30565180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion.
    Rezar-Dreindl S; Eibenberger K; Pollreisz A; Bühl W; Georgopoulos M; Krall C; Dunavölgyi R; Weigert G; Kroh ME; Schmidt-Erfurth U; Sacu S
    Acta Ophthalmol; 2017 Mar; 95(2):e119-e127. PubMed ID: 27417275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
    Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
    Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of foveal photoreceptor layer in eyes with macular edema associated with branch retinal vein occlusion after ozurdex treatment.
    Altunel O; Duru N; Goktas A; Ozkose A; Goktas E; Atas M
    Int Ophthalmol; 2017 Apr; 37(2):333-339. PubMed ID: 27221365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monthly microperimetry (MP1) measurement of macular sensitivity after dexamethasone implantation (Ozurdex) in retinal vein occlusions.
    Winterhalter S; Vom Brocke GA; Klamann MK; Müller B; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):1873-82. PubMed ID: 25576170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of choroidal thickness changes following intravitreal dexamethasone, ranibizumab, and triamcinolone in eyes with retinal vein occlusion.
    Yumusak E; Ornek K; Dikel NH
    Eur J Ophthalmol; 2016 Nov; 26(6):627-632. PubMed ID: 26847213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function.
    Querques G; Lattanzio R; Querques L; Triolo G; Cascavilla ML; Cavallero E; Del Turco C; Casalino G; Bandello F
    Retina; 2014 Feb; 34(2):330-41. PubMed ID: 23945638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHANGES IN SUBFOVEAL CHOROIDAL THICKNESS AFTER INTRAVITREAL DEXAMETHASONE IMPLANT THERAPY FOR DIABETIC MACULAR EDEMA.
    Moon KY; Choi SY; Song JH
    Retina; 2021 Jun; 41(6):1283-1292. PubMed ID: 33323903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group.
    Alshahrani ST; Dolz-Marco R; Gallego-Pinazo R; Diaz-Llopis M; Arevalo JF;
    Retina; 2016 Jan; 36(1):131-6. PubMed ID: 26079477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Dexamethasone Intravitreal Implant on Retinal Nerve Fiber Layer in Patients Diagnosed with Branch Retinal Vein Occlusion.
    Ayar O; Alpay A; Koban Y; Akdemir MO; Yazgan S; Canturk Ugurbas S; Ugurbas SH
    Curr Eye Res; 2017 Sep; 42(9):1287-1292. PubMed ID: 28632411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.